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Abstract: Multiple and unusual clinical features of cutaneous leishmaniasis (CL) had been reported as hyperkeratotic, 
psoriasiform, eczematoid, zosteriform pattern, warty lesions, erysipeloid, and acneiform lesions. The clinical features of 
CL primarily depend on the host's cell-mediated response and the species of Leishmania being involved. In this paper 
we reported two cases of atypical CL from Iran, Shohada-e-Tajrish and Loghman-e-Hakim hospitals presented with 
infiltrative erythematous lesions covering the perioral region and the lower limb, respectively. The diagnosis of cutaneous 
leishmaniasis was confirmed with skin smears and biopsies. 
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INTRODUCTION  
Cutaneous leishmaniasis (CL) is a parasitic 
infection encountered in daily dermatologic practice [1]. 
Iran has high rate of this widespread tropical infection 
[2]. Based on the geographic region where the infection 
is acquired, it is divided into two subsets: old world and 
new world. The causative organisms, vectors, 
reservoirs, clinical manifestations, and prognosis are 
different in these groups. Usual causes of old world CL 
are due to L. major or L. tropica [3]. The main 
reservoirs of this disease are infected patients and 
dogs [1]. The two forms usually begin as a small 
papule at the inoculation site; which gradually enlarges 
over several weeks into a nodule and then becomes 
ulcerated or verrucous. Exposed sites are most 
commonly involved. The majority of these lesions will 
resolve spontaneously with scar formation [3]. Atypical 
clinical presentations have been reported which include 
hyperkeratotic, psoriasiform, eczematoid, zosteriform 
pattern, massive auricular enlargement, diffuse 
cutaneous leishmaniasis with lymphoma like lesions, 
warty lesions, erysipeloid, and acneiform lesions [4-8]. 
Erysipeloid form is an uncommon manifestation of CL. 
This atypical clinical feature has been reported from 
Iran, Turkey, Pakistan and Tunisia [5, 9-11]. 
CASE PRESENTATION 
The first case was a 25-year-old man presented 
with a crusted, infiltrative and erythematous plaque on 
his perioral region. His history revealed that the lesion 
started from an asymptomatic and ulcerated papule on 
the upper labial region, then slowly enlarged and 
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involved his chin and perioral region (Figure 1). He had 
no significant past medical history except for traveling 
to an endemic area of CL in Iran. No lymphadenopathy, 
mucous membrane involvement, or systemic 
abnormalities were detected. Routine laboratory results 
were normal. A skin smear taken from the lesion was 
positive for CL with many amastigotes in the 
intracellular and extracullar area of the 
macrophages(Figure 2).  
 
Figure 1: (a), (b) A crusted and erythematous plaque on the 
chin and perioral region. 
 
 
Figure 2: The skin smear shows many amastigotes in the 
intracellular and extracellular area of the macrophages 
(Geimsa stain,  100). 
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The second case was a 40-year-old man presented 
with multiple erythematous indurated papules and 
plaques on his left shin, ankle and foot and ulcerative 
lesions on the posterior and anterior aspects of his left 
shin. He had traveled to an endemic area of CL in Iran.  
Also an ulcer with erythematous margin was observed 
on the third toe of the left foot (Figure 3). Physical 
examination of the mucous membranes and other 
organs was normal. The skin smear was positive for 
leishmania and the histopathologic examination of skin 
biopsy was positive for CL (Figure 4). 
 
Figure 4: Histopathologic examination of the skin biopsy 
shows numerous amastigotes in macrophages (H & E,  40). 
Both patients were treated intramuscularly with 10 
mg/kg/day systemic meglumine antimoniate. After 20 
days of systemic meglumine antimoniate therapy, 
marked improvement of lesions were observed. Two 
weeks after treatment, only scars were observed in the 
place of the ulcerated lesions (Figure 5).  
 
Figure 5: case 1: after treatment with systemic meglumine 
antimoniate. 
DISCUSSION  
 CL is one of the most important zoonotic diseases 
in Iran, and it is endemic problem in South and Central 
part of Iran. L.tropica and L.major cause this disease in 
Iran [2, 5]. It usually begins as a small papule which 
may gradually enlarge over several weeks into a 
nodule and become ulcerated [3]. This disease shows 
various symptoms depending on host’s cell- mediated 
immune system. The reasons for atypical presentation 
such as erysipeloid form are unclear, although 
alteration in host’s immune response, involvement of 
specific subtypes of parasite, changes in hormones 
and skin barrier can be considered as important factors 
[12]. 
Erysipeloid type of CL was first reported from Iran in 
1994 on the face of predominantly female patients [5]. 
In 1998, an erysipeloid case presented as an 
erythematous, indurated plaque over the right side of 
 
Figure 3: (a) Multiple erythematous indurated papules and plaques on the anterior aspect of the left leg and these lesions 
spread to his left toes. (b) Also an ulcer with erythematous margin existed on the third toe of the left foot. 
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the upper lip and adjacent cheek was reported [9]. In 
1999, Salmanpour et al reported five Iranian patients, 
predominantly females (50-70 years of age) presented 
with infiltrative erythematous lesions on the center of 
the face [12]. In 2004, Karincaoglu described an 
erysipeloid case of CL in a Turkish woman, presented 
with butterfly-shaped infiltrated erythematous plaque on 
the face, [10] and Ceyhan and colleagues reported a 
similar case that presented with ulceration on glabella 
and infiltrative erythematous lesions covering the 
center of the face. The diagnosis can be confirmed by 
the presence of amastigotes in dermal macrophages of 
skin biopsy, but Giemsa staining is used to detect 
leishmania in smear [1]. 
The differential diagnosis includes fungal infections, 
eczema, leprosy, atypical mycobacterial infections, 
sarcoidosis, lupus vulgaris, basal and squamous cell 
carcinomas, tuberculosis, infected insect bites and 
cutaneous metastasis of internal malignancies [13, 14]. 
Treatment depends on the region of the world in 
which the infection was acquired, the species of 
Leishmania, the site(s) and severity of the infection, 
and host factors such as immune status and age. Old 
world cutaneous leishmaniasis is often self-limiting and 
without treatment, typically resolves within 2-4 months 
(L. major) or 6-15 months (L. tropica). Pentavalent 
antimonials as sodium stibogluconate and meglumine 
antimoniate are standard treatment for cutaneous and 
mucocutaneous leishmaniasis. Cryotherapy, heat 
therapy (to 40-42°C for several hours each day), 
paromomycin (topically BID  10-20 days), miltefosine 
(2.5 mg/kg/day PO (max150 mg)  28 days), 
itraconazole (7 mg/kg/day PO  3 weeks), pentamidine 
(2-3 mg/kg IV or IM daily or every other day  4-7 
doses), amphotricine B (preferred treatment for visceral 
type), alluporinol (10-20 mg/kg for 6 to 8 weeks), 
ketoconazole (600 mg/day or 10 mg/kg/day PO  4 
weeks) are additional therapies used to treat CL. 
Plastic repair may be used for severe scarring [3, 15]. 
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